Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Epoetin beta with intravenous iron results in overall cost savings in a population of anemic patients with lymphoid malignancies not receiving chemotherapy
KTH, School of Architecture and the Built Environment (ABE), Transport and Economics, Safety Research.ORCID iD: 0000-0001-7606-8771
2007 (English)In: Blood, ISSN 0006-4971, E-ISSN 1528-0020, Vol. 110, no 11, 5179- p.Article in journal (Refereed) Published
Place, publisher, year, edition, pages
2007. Vol. 110, no 11, 5179- p.
Identifiers
URN: urn:nbn:se:kth:diva-17124ISI: 000251101102471OAI: oai:DiVA.org:kth-17124DiVA: diva2:335167
Note
QC 20100525Available from: 2010-08-05 Created: 2010-08-05 Last updated: 2017-12-12Bibliographically approved

Open Access in DiVA

No full text

Authority records BETA

Näsman, Per

Search in DiVA

By author/editor
Näsman, Per
By organisation
Safety Research
In the same journal
Blood

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 20 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf